Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FACETS: Migalastat in Fabry Disease
NCT00925301Phase 3Completed
- Sponsor
- Amicus Therapeutics
- Start
- Oct 2009
- Primary completion
- Jun 2012
- Modality
- Classical Binding Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of migalastat in Fabry disease (FD), sponsored by Amicus Therapeutics. Started Oct 2009; status: completed.
02
Drugs
migalastat
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT00925301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00925301.